Anti-PACT (PKR activating protein) / PRKRA antibody (ab82364)


  • Product nameAnti-PACT (PKR activating protein) / PRKRA antibody
    See all PACT (PKR activating protein) / PRKRA primary antibodies
  • Description
    Rabbit polyclonal to PACT (PKR activating protein) / PRKRA
  • Tested applicationsSuitable for: WB, ELISAmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide selected from S246 region of Human PACT (PKR activating protein)/ PRKRA conjugated to KLH (NP_003681)

  • Positive control
    • HL60 cell line lysates.


Associated products


Our Abpromise guarantee covers the use of ab82364 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/50 - 1/100. Detects a band of approximately 34 kDa (predicted molecular weight: 34 kDa).
ELISA 1/1000.


  • FunctionActivates EIF2AK2/PKR in the absence of double stranded RNA (dsRNA), leading to phosphorylation of EIF2S1/EFI2-alpha and inhibition of translation and induction of apoptosis. Required for siRNA production by DICER1 and for subsequent siRNA-mediated post-transcriptional gene silencing. Does not seem to be required for processing of pre-miRNA to miRNA by DICER1.
  • Involvement in diseaseDefects in PRKRA are the cause of dystonia type 16 (DYT16) [MIM:612067]. DYT16 is an early-onset dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT16 patients have progressive, generalized dystonia with axial muscle involvement, oro-mandibular (sardonic smile) and laryngeal dystonia and, in some cases, parkinsonian features.
  • Sequence similaritiesBelongs to the PRKRA family.
    Contains 3 DRBM (double-stranded RNA-binding) domains.
  • DomainSelf-association may occur via interactions between DRBM domains as follows: DRBM 1/DRBM 1, DRBM 1/DRBM 2, DRBM 2/DRBM 2 or DRBM 3/DRBM3.
  • Post-translational
    Phosphorylated at Ser-246 in unstressed cells and at Ser-287 in stressed cells. Phosphorylation at Ser-246 appears to be a prerequisite for subsequent phosphorylation at Ser-287. Phosphorylation at Ser-246 and Ser-287 are necessary for activation of EIF2AK2/PKR under conditions of stress.
  • Cellular localizationCytoplasm > perinuclear region.
  • Information by UniProt
  • Database links
  • Alternative names
    • DYT16 antibody
    • HSD14 antibody
    • Interferon inducible double stranded RNA dependent protein kinase activator A antibody
    • interferon-inducible double stranded RNA-dependent activator antibody
    • Interferon-inducible double stranded RNA-dependent protein kinase activator A antibody
    • PACT antibody
    • PKR associated protein X antibody
    • PKR associating protein X antibody
    • PKR-associated protein X antibody
    • PKR-associating protein X antibody
    • PRKRA antibody
    • PRKRA_HUMAN antibody
    • Protein activator of the interferon induced protein kinase antibody
    • Protein activator of the interferon-induced protein kinase antibody
    • Protein kinase antibody
    • Protein kinase interferon inducible double stranded RNA dependent activator antibody
    • RAX antibody
    see all

Anti-PACT (PKR activating protein) / PRKRA antibody images

  • Anti-PACT (PKR activating protein) / PRKRA antibody (ab82364) at 1/50 dilution + HL60 cell line lysates at 35 µg

    Predicted band size : 34 kDa
    Observed band size : 34 kDa

References for Anti-PACT (PKR activating protein) / PRKRA antibody (ab82364)

ab82364 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab82364.
Please use the links above to contact us or submit feedback about this product.